Loading news article.

Newsfiscal.ai

Faeth Therapeutics to Present Preclinical Data on PIKTOR at ESMO 2026

Oct 20, 2026, 09:02 ET · Published

Article summary

Faeth Therapeutics, a subsidiary of Sensei Biotherapeutics, announced it will present preclinical data on its lead oncology program, PIKTOR, at the European Society for Medical Oncology (ESMO) Congress 2026.

An excerpt from the original article.

Related companies

Faeth Therapeutics, Inc. Common StockFTHView stock

Analyzed by WAPE AI.

Preparing English content…

Repost

Comments —

Loading comments…